15.12.2024 03:05:42

Catalent And Novo Holdings Complete All Regulatory Closing Conditions For Merger

(RTTNews) - Catalent Inc. (CTLT) and Novo Holdings A/S announced that the companies have fulfilled all regulatory closing conditions for their pending transaction. The companies now expect to close the transaction in the coming days.

In February 2024, Catalent agreed to be acquired by Novo Holdings in an all-cash transaction worth enterprise value of $16.5 billion. The acquisition at $63.50 per share in cash represents a premium of 16.5 percent to the closing price of Catalent's common stock as of February 2, 2024. Upon the completion of the merger, Catalent would become a private company.

Analysen zu Novo Nordisk (spons. ADRs)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Catalent Inc 60,00 -0,79% Catalent Inc
Novo Nordisk (spons. ADRs) 103,00 -0,96% Novo Nordisk (spons. ADRs)